Home » Stocks » ZSAN

Zosano Pharma Corporation (ZSAN)

Stock Price: $1.12 USD 0.05 (4.21%)
Updated Mar 8, 2021 3:51 PM EST - Market open
Market Cap 109.21M
Revenue (ttm) n/a
Net Income (ttm) -34.21M
Shares Out 77.88M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 8
Last Price $1.12
Previous Close $1.07
Change ($) 0.05
Change (%) 4.21%
Day's Open 1.08
Day's Range 1.04 - 1.19
Day's Volume 3,853,782
52-Week Range 0.33 - 3.06

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 6 days ago

FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive ...

GlobeNewsWire - 2 weeks ago

FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the offici...

InvestorPlace - 3 weeks ago

Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Share...

GlobeNewsWire - 1 month ago

FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtry...

Zacks Investment Research - 1 month ago

Zosano Pharma (ZSAN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

InvestorPlace - 2 months ago

News that migraine-treatment maker Zosano Pharma will reapproach the FDA for approval has ZSAN stock jumping this morning. Investors should be cautious as penny stocks can cause big headaches.

GlobeNewsWire - 2 months ago

FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on December 30, 2020 the company re...

GlobeNewsWire - 2 months ago

FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive o...

Business Wire - 2 months ago

LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Zosano Pharma Corporation.

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 28, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...

Business Wire - 2 months ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDA...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NAS...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 25, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in th...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

PRNewsWire - 2 months ago

NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13,...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 24, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

GlobeNewsWire - 2 months ago

Investors with losses are encouraged to contact the firm before December 28, 2020 ; click here to submit trade information

Business Wire - 2 months ago

NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the ...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 21, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 17, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired sec...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 17, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) ...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 17, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...

GlobeNewsWire - 2 months ago

LOS ANGELES, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class act...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 15, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired sec...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 14, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NAS...

PRNewsWire - 2 months ago

LOS ANGELES, Dec. 14, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class action ...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Zosano Pharma Corporation (NASDAQ: ZSAN) between ...

PRNewsWire - 2 months ago

NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13,...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 10, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 9, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 8, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASD...

GlobeNewsWire - 3 months ago

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...

GlobeNewsWire - 3 months ago

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 7, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 7, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) be...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 4, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 3, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...

PRNewsWire - 3 months ago

NEW YORK, Dec. 3, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN) and certa...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 1, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

GlobeNewsWire - 3 months ago

LOS ANGELES, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class act...

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...

About ZSAN

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its intracutaneous microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Industry
Biotechnology
IPO Date
Jan 27, 2015
CEO
Steven Lo
Employees
56
Stock Exchange
NASDAQ
Ticker Symbol
ZSAN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Zosano Pharma stock is "Buy." The 12-month stock price forecast is 1.83, which is an increase of 64.13% from the latest price.

Price Target
$1.83
(64.13% upside)
Analyst Consensus: Buy